125 related articles for article (PubMed ID: 16164216)
1. [Diagnosis and prediction of joint destruction found in patients with rheumatoid arthritis using by biochemical markers].
Eguchi K
Nihon Rinsho; 2005 Sep; 63(9):1586-93. PubMed ID: 16164216
[TBL] [Abstract][Full Text] [Related]
2. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
Garnero P; Gineyts E; Christgau S; Finck B; Delmas PD
Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
[TBL] [Abstract][Full Text] [Related]
3. [Usefulness of serum matrix metalloproteinase-3(MMP-3) level in the diagnosis of rheumatoid arthritis].
Yamanaka H
Nihon Rinsho; 2002 Dec; 60(12):2325-30. PubMed ID: 12510357
[TBL] [Abstract][Full Text] [Related]
4. [Role of matrix metalloproteinase-3 in joint destruction in rheumatoid arthritis].
Sugiyama E
Clin Calcium; 2007 Apr; 17(4):528-34. PubMed ID: 17404481
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
6. High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion.
Fujikawa K; Kawakami A; Tamai M; Uetani M; Takao S; Arima K; Iwamoto N; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Aoyagi K; Eguchi K
J Rheumatol; 2009 Jun; 36(6):1126-9. PubMed ID: 19447929
[TBL] [Abstract][Full Text] [Related]
7. [Stromelysin-1 (MMP-3) level in the sera from patients with rheumatoid arthritis and other connective tissue diseases--clinical significances in early onset rheumatoid arthritis].
Shingu M; Obata K; Ezaki I; Tomari K; Fujikawa Y; Wada T; Nonaka S; Suenaga Y; Iwata K; Nobunaga M
Ryumachi; 1995 Feb; 35(1):15-24. PubMed ID: 7732485
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases MMP-3 and MMP-1 levels in sera and synovial fluids in patients with rheumatoid arthritis and osteoarthritis.
Mahmoud RK; El-Ansary AK; El-Eishi HH; Kamal HM; El-Saeed NH
Ital J Biochem; 2005; 54(3-4):248-57. PubMed ID: 16688934
[TBL] [Abstract][Full Text] [Related]
9. [New diagnostic tests for rheumatoid arthritis].
Hayashi N; Kumagai S
Rinsho Byori; 2003 Oct; 51(10):1030-5. PubMed ID: 14653204
[TBL] [Abstract][Full Text] [Related]
10. [Early prediction of joint destruction in rheumatoid arthritis].
Eguchi K
Clin Calcium; 2007 Apr; 17(4):517-25. PubMed ID: 17404480
[TBL] [Abstract][Full Text] [Related]
11. Changes in biochemical markers of joint tissue metabolism in a randomized controlled trial of glucocorticoid in early rheumatoid arthritis.
Sharif M; Salisbury C; Taylor DJ; Kirwan JR
Arthritis Rheum; 1998 Jul; 41(7):1203-9. PubMed ID: 9663476
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
Chopin F; Garnero P; le Henanff A; Debiais F; Daragon A; Roux C; Sany J; Wendling D; Zarnitsky C; Ravaud P; Thomas T
Ann Rheum Dis; 2008 Mar; 67(3):353-7. PubMed ID: 17644538
[TBL] [Abstract][Full Text] [Related]
13. [A basic study of determination matrix metalloproteinase-3 and carbohydrate in rheumatoid factor in serum for diagnosis of rheumatoid arthritis].
Urata M; Nakamura N; Kinoshita S; Kayamori Y; Hamasaki N
Rinsho Byori; 2003 Aug; 51(8):745-50. PubMed ID: 13677934
[TBL] [Abstract][Full Text] [Related]
14. [Levels of matrix metalloproteinase-3 and urokinase-type plasminogen activator in knee synovial fluids from patients with rheumatoid arthritis and osteoarthritis].
Gotoh H; Yamada H; Yoshihara Y; Kikuchi T; Obata K; Shinmei M
Ryumachi; 1997 Feb; 37(1):3-8. PubMed ID: 9128417
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
16. [New biomarkers for rheumatoid arthritis].
Hayashi N; Nishimura K; Kumagai S
Rinsho Byori; 2008 Apr; 56(4):297-308. PubMed ID: 18516964
[TBL] [Abstract][Full Text] [Related]
17. [Correlations between serum matrix metalloproteinase (MMP-1, MMP-3, MMP-9, MMP-13) concentrations and markers of disease activity in early rheumatoid arthritis].
Fiedorczyk M; Klimiuk PA; Sierakowski S; Domysławska I; Chwiećko J
Przegl Lek; 2005; 62(12):1321-4. PubMed ID: 16786739
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of MMP-3 in patients with rheumatoid arthritis: comparison with other inflammatory markers(IL-6, IL-8)].
Hamakawa H; Takemura M; Sato M; Shinohe R; Koishi H; Furuta N; Ohta H; Koike N; Iwamoto N; Yamada Y; Wada H; Saito K; Seishima M
Rinsho Byori; 2003 Jan; 51(1):13-8. PubMed ID: 12652686
[TBL] [Abstract][Full Text] [Related]
19. [Topics on immunological tests for rheumatoid arthritis].
Kumagai S; Nishimura K; Hayashi N
Rinsho Byori; 2004 Oct; 52(10):836-43. PubMed ID: 15624500
[TBL] [Abstract][Full Text] [Related]
20. Effect of matrix metalloproteinase-3 functional SNP on serum matrix metalloproteinase-3 level and outcome measures in Japanese RA patients.
Tsukahara S; Shinozaki M; Ikari K; Mochizuki T; Inoue E; Tomatsu T; Hara M; Yamanaka H; Kamatani N; Momohara S
Rheumatology (Oxford); 2008 Jan; 47(1):41-4. PubMed ID: 18077489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
